Troutman Pepper advised Trevena on the deal.Trevena, a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS)…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
